173 related articles for article (PubMed ID: 26489119)
21. [Cyclosporin A eyedrops for keratitis nummularis after adenovirus keratoconjunctivitis].
Böhringer D; Birnbaum F; Reinhard T
Ophthalmologe; 2008 Jun; 105(6):592-4. PubMed ID: 18365204
[TBL] [Abstract][Full Text] [Related]
22. Symptomatic Treatment of Subepithelial Infiltrates after Viral Conjunctivitis: Loteprednol or Dexamethasone?
Koçluk Y; Sukgen EA; Cevher S; Mat E
Ocul Immunol Inflamm; 2017 Oct; 25(5):649-653. PubMed ID: 27015587
[TBL] [Abstract][Full Text] [Related]
23. [Effectiveness of soft contact lenses in severe keratoconjunctivitis sicca treated with local immunosuppressive therapy].
Safonova TN; Gladkova OV; Boev VI; Fedorov AA
Vestn Oftalmol; 2016; 132(5):39-48. PubMed ID: 27911424
[TBL] [Abstract][Full Text] [Related]
24. [Significance of laser confocal tomography in diagnosis and monitoring of keratoconjunctivitis sicca].
Safonova TN; Gladkova ОV; Boev VI
Vestn Oftalmol; 2016; 132(2):47-54. PubMed ID: 27213797
[TBL] [Abstract][Full Text] [Related]
25. Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
Levinger E; Trivizki O; Shachar Y; Levinger S; Verssano D
Graefes Arch Clin Exp Ophthalmol; 2014 May; 252(5):811-6. PubMed ID: 24696044
[TBL] [Abstract][Full Text] [Related]
26. [0.05% cyclosporine a for treatment of chronic severe ocular surface disease].
Nochez Y; Denoyer A; Pisella PJ
Can J Ophthalmol; 2009 Aug; 44(4):406-11. PubMed ID: 19606161
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.
Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L
Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the impact of persistent subepithelial corneal infiltrations on the visual performance and corneal optical quality after epidemic keratoconjunctivitis.
Aydin Kurna S; Altun A; Oflaz A; Karatay Arsan A
Acta Ophthalmol; 2015 Jun; 93(4):377-82. PubMed ID: 25043311
[TBL] [Abstract][Full Text] [Related]
29. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
Sahin A; Bozkurt B; Irkec M
Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575
[TBL] [Abstract][Full Text] [Related]
30. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
Tzu JH; Utine CA; Stern ME; Akpek EK
Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
[TBL] [Abstract][Full Text] [Related]
31. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
[TBL] [Abstract][Full Text] [Related]
32. Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment.
Utine CA; Stern M; Akpek EK
Ocul Immunol Inflamm; 2019; 27(7):1184-1193. PubMed ID: 30189151
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the effect of cyclosporine-A 0.05% emulsion on the ocular surface and corneal sensation following cataract surgery.
Hamada S; Moore TC; Moore JE; Al-Dreihi MG; Anbari A; Shah S
Cont Lens Anterior Eye; 2016 Feb; 39(1):15-9. PubMed ID: 26275686
[TBL] [Abstract][Full Text] [Related]
34. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
[TBL] [Abstract][Full Text] [Related]
35. Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.
Malhotra R; Devries DK; Luchs J; Kabat A; Schechter BA; Shen Lee B; Shettle L; Smyth-Medina R; Ogundele A; Darby C; Bacharach J; Karpecki P
Cornea; 2019 Oct; 38(10):1259-1265. PubMed ID: 31306284
[TBL] [Abstract][Full Text] [Related]
36. Conjunctival in vivo confocal scanning laser microscopy in patients with atopic keratoconjunctivitis.
Hu Y; Adan ES; Matsumoto Y; Dogru M; Fukagawa K; Takano Y; Tsubota K; Fujishima H
Mol Vis; 2007 Aug; 13():1379-89. PubMed ID: 17768384
[TBL] [Abstract][Full Text] [Related]
37. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
Price MO; Price FW
Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
[TBL] [Abstract][Full Text] [Related]
39. Concurrent adenoviral and herpetic ocular infections.
Deutsch FH
Ann Ophthalmol; 1989 Nov; 21(11):432-8. PubMed ID: 2559639
[TBL] [Abstract][Full Text] [Related]
40. Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications.
Saini M; Dhiman R; Dada T; Tandon R; Vanathi M
Eye (Lond); 2015 Jun; 29(6):808-14. PubMed ID: 25857609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
